Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17540734rdf:typepubmed:Citationlld:pubmed
pubmed-article:17540734lifeskim:mentionsumls-concept:C1411976lld:lifeskim
pubmed-article:17540734lifeskim:mentionsumls-concept:C0041221lld:lifeskim
pubmed-article:17540734lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:17540734lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:17540734lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:17540734pubmed:issue3lld:pubmed
pubmed-article:17540734pubmed:dateCreated2007-8-28lld:pubmed
pubmed-article:17540734pubmed:abstractTextWe have demonstrated recently that the glycoinositolphospholipid (GIPL) molecule from the protozoan Trypanosoma cruzi is a TLR4 agonist with proinflammatory effects. Here, we show that GIPL-induced neutrophil recruitment into the peritoneal cavity is mediated by at least two pathways: one, where IL-1beta acts downstream of TNF-alpha, and a second, which is IL-1beta- and TNFRI-independent. Moreover, NKT cells participate in this proinflammatory cascade, as in GIPL-treated CD1d(-/-) mice, TNF-alpha and MIP-2 levels are reduced significantly. As a consequence of this inflammatory response, spleen and lymph nodes of GIPL-treated mice have an increase in the percentage of T and B cells expressing the CD69 activation marker. Cell-transfer experiments demonstrate that T and B cell activation by GIPL is an indirect effect, which relies on the expression of TLR4 by other cell types. Moreover, although signaling through TNFRI contributes to the activation of B and gammadelta+ T cells, it is not required for increasing CD69 expression on alphabeta+ T lymphocytes. It is interesting that T cells are also functionally affected by GIPL treatment, as spleen cells from GIPL-injected mice show enhanced production of IL-4 following in vitro stimulation by anti-CD3. Together, these results contribute to the understanding of the inflammatory properties of the GIPL molecule, pointing to its potential role as a parasite-derived modulator of the immune response during T. cruzi infection.lld:pubmed
pubmed-article:17540734pubmed:languageenglld:pubmed
pubmed-article:17540734pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:citationSubsetIMlld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17540734pubmed:statusMEDLINElld:pubmed
pubmed-article:17540734pubmed:monthSeplld:pubmed
pubmed-article:17540734pubmed:issn0741-5400lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:Van KaerLucLlld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:PreviatoJosé...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:Mendonça-Prev...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:BellioMariaMlld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:NobregaAlbert...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:Cardilo-ReisL...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:OliveiraAna-C...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:PeixotoJaquel...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:MedeirosMonic...lld:pubmed
pubmed-article:17540734pubmed:authorpubmed-author:KoatzVera L...lld:pubmed
pubmed-article:17540734pubmed:issnTypePrintlld:pubmed
pubmed-article:17540734pubmed:volume82lld:pubmed
pubmed-article:17540734pubmed:ownerNLMlld:pubmed
pubmed-article:17540734pubmed:authorsCompleteYlld:pubmed
pubmed-article:17540734pubmed:pagination488-96lld:pubmed
pubmed-article:17540734pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:meshHeadingpubmed-meshheading:17540734...lld:pubmed
pubmed-article:17540734pubmed:year2007lld:pubmed
pubmed-article:17540734pubmed:articleTitleToll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi.lld:pubmed
pubmed-article:17540734pubmed:affiliationInstituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, CCS Bloco I, 20 andar Sala: I2-051, Avenida Carlos Chagas Filho, 373, Cidade Universitária, Ilha do Fundão, CEP: 21941-902, Rio de Janeiro, RJ, Brazil.lld:pubmed
pubmed-article:17540734pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17540734pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12479entrezgene:pubmedpubmed-article:17540734lld:entrezgene
entrez-gene:21937entrezgene:pubmedpubmed-article:17540734lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540734lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17540734lld:pubmed